• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

Lead Plaintiff Defeats Motion to Dismiss in Part in In Re Health Insurance Innovations

Home»News»Lead Plaintiff Defeats Motion to Dismiss in Part in In Re Health Insurance Innovations

On June 28, 2019, the Hon. Elizabeth A. Kovachevich, United States District Court Judge for the Middle District of Florida, entered an Order denying, in part, defendants’ motion to dismiss. This matter, in which Kahn Swick & Foti is lead counsel, alleges that Health Insurance Innovations (“HII’s”) Quarterly Report for the Second Quarter of 2017 was misleading because it (i) conveyed the false impression that HII would not need a third party administrator (“TPA”) license to conduct its third-party insurance business in its home state of Florida and, (ii) misrepresented the reasons that the Florida Office of Insurance Regulation denied its application for a TPA license. Judge Kovachevitch agreed and also found the “pleaded facts demonstrate a strong inference that [Defendant Chief Financial Officer Michael] Hershberger acted with the requisite state of mind with respect to each act or omission alleged to violate the Exchange Act.”

Filed Under: News

Previous Post: « KSF Successfully Defended the Ninth Circuit’s Ruling in Orexigen Therapeutics Litigation
Next Post: Lead Plaintiff Defeats Motion to Dismiss in Orexigen Therapeutics Litigation »

Primary Sidebar

Current Cases

Apex Global Brands Inc. (OTC: APEX)

Forterra, Inc. (NasdaqGS: FRTA)

PRA Health Sciences, Inc. (NasdaqGS: PRAH)

Pandion Therapeutics, Inc. (NasdaqGS: PAND)

Boingo Wireless, Inc. (NasdaqGS: WIFI)

Inovio Pharmaceuticals Inc. (NasdaqGS: INO)

see more»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2021 Copyright. All rights reserved Kahn Swick & Foti LLC · New Orleans · New York — Kahn Swick & Foti LLP · San Francisco